Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin H Preller

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Addiction Biology|November 10, 2015
α<sub>2A</sub> -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine usersMichael M Havranek, Lea M Hulka, Eve Tasiudi, et al.
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanismsDrummond E-Wen McCulloch, Juan Pablo Lopez, Christina Dalla, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2015
Serotonin Transporter and Tryptophan Hydroxylase Gene Variations Mediate Working Memory Deficits of Cocaine UsersMichael M Havranek, Matthias Vonmoos, Christian P Müller, et al.
Brain : a Journal of Neurology|October 22, 2025
Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densitiesRebecca C Coray, Vincent Beliveau, Josua Zimmermann, et al.
Eclinicalmedicine|January 13, 2023
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trialRobin von Rotz, Eva M Schindowski, Johannes Jungwirth, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 13, 2017
Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humansOliver G Bosch, Michael M Havranek, Andrea Baumberger, et al.
Eclinicalmedicine|February 7, 2023
Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'Robin von Rotz, Eva M Schindowski, Johannes Jungwirth, et al.
Drug and Alcohol Dependence|April 18, 2016
Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine useMichael D Wunderli, Matthias Vonmoos, Stefania M Niedecker, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 17, 2023
Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and MeditationFlora Moujaes, Nathalie M Rieser, Christophe Phillips, et al.
Neuroimage. Clinical|August 28, 2023
Accumbal-thalamic connectivity and associated glutamate alterations in human cocaine craving: A state-dependent rs-fMRI and <sup>1</sup>H-MRS studyEtna J E Engeli, Andrea G Russo, Sara Ponticorvo, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Addiction Biology|November 10, 2015
α<sub>2A</sub> -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine usersMichael M Havranek, Lea M Hulka, Eve Tasiudi, et al.
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanismsDrummond E-Wen McCulloch, Juan Pablo Lopez, Christina Dalla, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2015
Serotonin Transporter and Tryptophan Hydroxylase Gene Variations Mediate Working Memory Deficits of Cocaine UsersMichael M Havranek, Matthias Vonmoos, Christian P Müller, et al.
Brain : a Journal of Neurology|October 22, 2025
Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densitiesRebecca C Coray, Vincent Beliveau, Josua Zimmermann, et al.
Eclinicalmedicine|January 13, 2023
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trialRobin von Rotz, Eva M Schindowski, Johannes Jungwirth, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 13, 2017
Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humansOliver G Bosch, Michael M Havranek, Andrea Baumberger, et al.
Eclinicalmedicine|February 7, 2023
Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'Robin von Rotz, Eva M Schindowski, Johannes Jungwirth, et al.
Drug and Alcohol Dependence|April 18, 2016
Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine useMichael D Wunderli, Matthias Vonmoos, Stefania M Niedecker, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 17, 2023
Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and MeditationFlora Moujaes, Nathalie M Rieser, Christophe Phillips, et al.
Neuroimage. Clinical|August 28, 2023
Accumbal-thalamic connectivity and associated glutamate alterations in human cocaine craving: A state-dependent rs-fMRI and <sup>1</sup>H-MRS studyEtna J E Engeli, Andrea G Russo, Sara Ponticorvo, et al.
Pageof 11